// App-Quantinova.ai

P30 : In vivo administration of immune checkpoint inhibitors prior to tumor harvest enhances the function of tumor-infiltrating T lymphocytes expanded for adoptive T cell transfer

Researchers

Presenter

  • Sandy Pelletier

Principal Investigators

  • John Stagg

  • Simon Turcotte

Medical Centers

  • CRCHUM, Montreal, QC, Canada

Locations

  • Canada

Companies

  • N/A

Study Components

Therapeutic Area

  • Oncology (ONC)

Disease

  • Colorectal Cancer

Biomarkers

  • tumor-infiltrating lymphocytes

Drug/Treatment

  • N/A

Outcome

  • Unknown

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • Interim

Copyright © 2026. QuantiNova All rights reserved